Evidence map›Paper›PMID 39554413›Full record

ArticleACS omega2024

Enhanced Delivery and Potency of Chemotherapeutics in Melanoma Treatment via Magnetite Nanobioconjugates.

Erika Díaz, Valentina Quezada, Javier Cifuentes, Nydia Yadira Arias Morales, Luis H Reyes, Carolina Muñoz-Camargo, Juan C Cruz

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in ACS omega, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Review
  3. FeNanomaterials (Basel, Switzerland) · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Erika DíazDepartment of Biomedical Engineering, Universidad de Los Andes, Bogotá 111711, Colombia.
Valentina QuezadaDepartment of Biomedical Engineering, Universidad de Los Andes, Bogotá 111711, Colombia.
Javier CifuentesDepartment of Biomedical Engineering, Universidad de Los Andes, Bogotá 111711, Colombia.ORCID https://orcid.org/0000-0003-0916-3909
Nydia Yadira Arias MoralesCenter for Microscopy (MicroCore), Vice Presidency for Research and Creation, Universidad de Los Andes, Bogotá 111711, Colombia.
Luis H ReyesProduct and Process Design Group (GDPP), Department of Chemical and Food Engineering, Universidad de Los Andes, Bogotá 111711, Colombia.ORCID https://orcid.org/0000-0001-7251-5298
Carolina Muñoz-CamargoDepartment of Biomedical Engineering, Universidad de Los Andes, Bogotá 111711, Colombia.ORCID https://orcid.org/0000-0001-6238-9021
Juan C CruzDepartment of Biomedical Engineering, Universidad de Los Andes, Bogotá 111711, Colombia.ORCID https://orcid.org/0000-0002-7790-7546

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Melanoma, known for its aggressive metastatic potential, poses significant treatment challenges. Despite the potent antiproliferative effects of anticancer drugs, systemic toxicity and low water solubility limit their efficacy. This study addresses these challenges by employing magnetite (Fe

Identifiers

PMID39554413
PMCPMC11561594

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.